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Purpose: To evaluate the association profiles of the lysyl oxidase-like 1 (LOXL1) gene polymorphisms with exfoliation
syndrome in a Chinese population.
Methods: Fifty unrelated patients with exfoliation syndrome and 125 control subjects were included. Genotypes of the
three single nucleotide polymorphisms (SNPs) of LOXL1 (rs1048661, rs3825942, and rs2165241) were analyzed by direct
sequencing, and a case-control association study was performed.
Results: The three SNPs were significantly associated with exfoliation syndrome (XFS) and exfoliation glaucoma (XFG)
individually. After controlling for rs3825942 and rs2165241, the association between rs1048661 and XFS/XFG remained
significant (p=3.6×10-7). At this SNP, the T allele and TT genotype conferred a 7.59-(95% confidence interval [CI]: 3.87–
14.89, p=6.95×10-11) and 8.69-(95% CI: 4.15–18.20, p<1.00×10-7) fold increased risk to the disease. The alleles of T at
rs1048661 and C at rs2165241 were found to be risk alleles in Chinese subjects, which were opposite to Caucasian
individuals.  The  haplotypes  T-G,  defined  by  SNPs  rs1048661  and  rs3825942,  and  T-C  by  SNPs  rs1048661  and
rs2165241, were also significantly associated with the disorder. However when the genotypic or allelic frequencies of the
three SNPs were compared between XFS and XFG, no significant difference was detected.
Conclusions: LOXL1 is a susceptibility gene of XFS/XFG in the Chinese population, and the association is mainly
attributed to SNP rs1048661. The risk alleles of rs1048661 and rs2165241 in Chinese subjects were found to be opposite
to that of Caucasians. The genotypic and allelic distributions of these SNPs are similar between XFS and XFG.
Exfoliation syndrome (XFS) is an age-related disorder of
the extracellular matrix in which abnormal fibrillar material
is  produced  and  progressively  accumulated  in  tissues
throughout the anterior segment and also in the connective
tissues  of  various  viscera.  The  clinical  features  of  this
disorder, which was initially described by Lindberg in 1917
[1], are deposition of white flake-like material on the anterior
lens  surface,  the  pupillary  border,  trabecular  meshwork,
zonula, ciliary body, and other anterior segment structures.
XFS is a common identifiable cause for secondary glaucoma,
i.e., exfoliation glaucoma (XFG), which is characterized by
rapid progression, high resistance to medical therapy, and
poor prognosis. XFS can not only lead to severe chronic open-
angle glaucoma but also to acceleration of cataract formation,
lens  subluxation,  angle  closure  glaucoma,  and  severe
complications  at  the  time  of  cataract  extraction,  such  as
zonular dialysis, capsular rupture, and vitreous loss [1–4].
XFS is also a systemic disorder that is primarily related to
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vasculopathy,  including  transient  ischemic  attack,
hypertension, angina, and myocardial infarction [1-4].
The  prevalence  of  XFS  varies  greatly  among  ethnic
groups,  with  a  prevalence  of  10–20%  among  the  elderly
populations of Finland [5,6], Iceland [7], Sweden [8], and
Greece [9], while being 0% in Greenland Eskimos [10,11]. In
Asian populations, the prevalence is relatively lower, being
3.01–6.28% in Indians aged over 40 years [12,13], 3.4% in
Japanese aged over 50 years [14], 0.4% in Hong Kong Chinese
aged over 60 years [15], and 0.2% and 0.7% in Singaporean
Chinese aged over 40 and 60 years, respectively [16].
So far, the exact cause of the production of exfoliation
material is still unknown, but there is evidence showing that
genetic factors may play an important role in the pathogenesis
of XFS [6,10,17–23]. Ethnic differences in the prevalence of
XFS, positive family history of XFS, increased risk for XFS
in relatives [6,18–20,22], and twin studies [17] support the
inheritance of XFS. Multiple inheritance patterns have been
suggested, but no clear pattern is evident, implying that XFS
is  a  complex  disorder  [6,10,19,22,23].  A  genome-wide
linkage study has reported a promising genetic locus on 18q
as well as other potential loci [24].
Recently,  a  genome-wide  association  study  in  the
Icelandic and Swedish populations indicated that three single
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(The first two authors contributed equally to this work)nucleotide polymorphisms (SNPs) in the lysyl oxidase-like 1
(LOXL1)  gene  on  chromosomal  region  15q24  were
significantly associated with XFS and XFG [25]. The three
SNPs are rs2165241 in the first intron and rs1048661 and
rs3825942  in  the  first  exon  of  the  gene,  which  lead  to
substitution of amino acids at position 141 and 153, denoted
as R141L and G153D, respectively [25]. LOXL1 is one of the
five lysyl oxidase family members that catalyzes oxidative
deamination of lysine residues of tropoelastin, which leads to
the spontaneous cross-linking with consequential formation
of  elastin  polymer  fibers  [25–27].  Studies  showed  that
LOXL  knockout  mice  have  diffuse  connective  tissue-
associated  changes  secondary  to  failed  elastic  fiber
homeostasis [27–29]. XFS is proposed to arise from abnormal
production  and  aggregation  of  elastin  microfibrillar
components produced by various cell types of the eye and
other  extraocular  tissues  [1,3,30].  Moreover,  LOXL1  and
elastin were found to be expressed in various ocular tissues,
and LOXL1 mRNA expression was differentially regulated
dependent on the phase of progression of the fibrotic process
and  stages  of  XFS  syndrome  [30,31].  Therefore,  the
hypothesis  that  defects  in  LOXL1  may  cause  XFS  is
biologically reasonable.
The association between XFS and the three LOXL1 SNPs
has been confirmed in other Caucasian [31–38] and Indian
populations  [39].  In  the  Japanese  population,  the  SNPs
rs1048661 and rs2165241 also showed association with XFS,
but the risk alleles were opposite to the Caucasian study [40–
45]. So far, however, the role of these SNPs in XFS has rarely
been studied in the Chinese population except one study in
Singaporean Chinese in which rs3825942 was found to be
associated with the disorder but no association was found for
rs1048661  [46].  Therefore,  this  study  was  conducted  to
investigate the association between the LOXL1 variants and
XFS in the Chinese population.
METHODS
Study  subjects:  The  diagnostic  criterion  for  exfoliation
syndrome  is  the  existence  of  exfoliation  material  on  the
anterior lens capsule with dilation of the pupils or on the pupil
margin in either eye. Patients with intraocular pressure (IOP)
of  less  than  21  mmHg  and  no  clinical  evidence  of
glaucomatous optic neuropathy were classified as XFS. While
exfoliation glaucoma (XFG) was diagnosed if the patient had
the  above  characteristics  of  exfoliation  syndrome  and  the
following features: (1) IOP ≥22 mmHg in either eye; (2)
glaucomatous changes on the optic disc, defined as cup to disc
ratio >0.7 in either eye or an asymmetric cup to disc ratio of
>0.2  or  notching  of  the  disc  rim;  and  (3)  characteristic
glaucomatous visual field loss [47]. Cases with other causes
for secondary glaucoma, such as uveitis, pigment dispersion
syndrome,  and  iridocorneal  endothelial  syndrome,  were
excluded. The patients were recruited from the following five
hospitals,  which  were  located  in  or  near  Beijing:  Beijing
Tongren Hospital, XingTai Eye Hospital, Peking University
Third  Hospital,  Handan  Eye  Hospital,  and  Anyang  Eye
Hospital. Controls were individuals randomly selected from
a population-based healthy entity in which 6830 people were
recruited  in  a  previous,  comprehensive,  ophthalmic,
epidemiologic study in a county in north China near Beijing
[48]. The controls were enrolled by the following criteria: (1)
having no signs of XFS or XFG, (2) no glaucomatous changes
on optic disc, (3) normal visual field and intraocular pressure,
(4)  no  family  history  of  glaucoma,  and  (5)  no  other  eye
diseases  except  mild  refractive  errors.  As  exfoliation
syndrome is a late-onset disorder and rarely develops before
the age of 50 years, only individuals aged 50 years or above
were included into this study as controls. All study subjects
were unrelated Han Chinese. They received comprehensive
ophthalmic examinations, including visual acuity testing and
refraction, Goldmann applanation tonometry, gonioscopy, slit
lamp biomicroscopy in mydriasis, fundus examination, and
automated static perimetry (Humphrey Visual Field Analyzer;
Carl Zeiss Ophthalmic Systems, Inc. Humphrey Division,
Dublin, CA). Peripheral venous blood was obtained from each
subject.
The  research  protocol  was  approved  by  the  ethics
committee for human research of Beijing Tongren Hospital,
Capital  Medical  University  in  Beijing,  China.  Informed
consent was obtained from all participants after explaining the
objective and nature of the study. The study was conducted in
accordance with the Declaration of Helsinki.
Analysis  of  LOXL1  polymorphisms:  Genomic  DNA  was
extracted  from  whole  blood  by  using  the  Genomic  DNA
Extraction Kit, (Ebioshine Beijing Biotechnology Co., Ltd.,
Beijing, China). The three SNPs (rs1048661, rs3825942, and
rs2165241) in the LOXL1 gene, according to the previous
report, were amplified by PCR and were directly sequenced
[25]. Two sets of primers were used for amplification by PCR
(Table  1).  The  PCR  protocol  was  as  follows:  initial
denaturation at 94 oC/5 min, followed by 10 cycles (94 oC/30
s, 65–60 oC touchdown for 1 min with 0.5 oC decrement, 72
oC/45 s), 30 cycles (94 oC /30 s, 60 oC /1 min, 72 oC /45 s), and
a  final  extension  at  72  oC/1  min.  Genotypes  of  the  three
LOXL1 SNPs were determined by direct DNA sequencing,
using  BigDye  Terminator  v3.1  Kit  (Applied  Biosystems,
Foster City, CA) in a 3730XL capillary sequencer (Applied
Biosystems). The sequences were analyzed by Sequencing
Analysis software v5.2 (Applied Biosystems).
Statistical  analysis:  Hardy–Weinberg  equilibrium  (HWE)
was tested by using the χ2 test in SAS Genetics (v9.1, SAS
Institute  Inc.,  Cary,  NC).  The  comparison  of  allelic  and
genotypic frequencies between case and control groups as
well as haplotype association analysis was performed using a
standard χ2 test with SAS Genetics. The Bonferroni method
was used for the adjustment of multiple comparisons, with a
p  value  of  less  than  0.017  (0.05/3)  being  considered  as
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intervals (CI) were estimated by the SAS Genetics software
and SPSS software (ver.12.0, SPSS inc., Chicago, IL). In
order  to  exploit  the  major  SNP  that  contribute  to  the
association between LOXL1 and the disorder, a conditional
haplotype-based  association  test  was  performed  using
PLINK (v1.06, Shaun Purcell) [49].
The  SNP  that  has  independent  haplotyic  effect  and
explains  the  omnibus  association  is  considered  as  the
predominant  SNP.  The  allelic  and  genotypic  association
analysis as well as haplotype association analysis were also
cross-checked  with  PLINK.  The  allelic,  genotypic  and
haplotype frequencies between two sub-phenotypes, i.e., XFS
without  glaucoma  and  XFG,  were  compared  using  the
methods mentioned above. Pairwise linkage disequilibrium
(LD)  analysis  among  the  three  SNPs  was  performed  in
Haploview (ver. 4.0, Daly Lab, Broad Institute, Cambridge,
MA).  The  sensitivity  (SE),  specificity  (SP),  positive  and
negative  predictive  values  (PPV  and  NPV)  of  the  at-risk
alleles, and genotypes for the three SNPs were calculated to
evaluate their abilities of predicting the affection status using
the adjusted estimation methods [50] ( the prevalence of XFS
was estimated to be 0.2% [16]).
RESULTS
A total of 50 patients with exfoliation syndrome, including 43
cases with XFG and seven cases with XFS without glaucoma,
as well as 125 control individuals were recruited into this
study. The age at recruitment was 54–87 years (mean age
70.4±7.6 years) in cases, 54–80 years (mean age 63.8±5.1
years) in controls. The gender distribution between cases and
controls was not significantly different (p=0.593), with 31
(62.0%)  males  and  19  (38.0%)  females  in  cases  and  72
(57.6%) males in controls. The IOP of the controls was 9–
20.25 mmHg (mean IOP 14.18±2.25 mmHg). The clinical
features of the patients are shown in Table 2. Thirty out of the
43 XFG patients had severe glaucoma and had trabeculectomy
more than once, and 20 cases were treated with medicine.
Unequivocal genotypes of the three SNPs were obtained
from both patients and controls. The genotype distribution of
SNP rs1048661 deviated slightly from the HWE in controls
(p=0.0245). SNPs rs3825942 and rs2165241 followed the
HWE  in  controls  (p=0.53  for  rs3825942  and  p=0.21  for
rs2165241,  respectively).  We  further  checked  the
reproducibility of genotyping of rs1048661 by re-performing
DNA sequencing. The results were in complete agreement
TABLE 1. PRIMER SEQUENCES FOR PCR FOR SNPS OF LOXL1.
Amplicon Primer sequences Size (bp)
rs1048661
and rs3825942*
F: 5’-CAACGGGCAGGTGTACAGCTT-3’ 441
R: 5’-GCGGGGTCGTAGTTCTCGTAC-3’
rs2165241 F: 5’-CTCTAGGGCCCCTTGGAGAAT-3’ 321
R: 5’-GGCCAGAGGTCTGCTAAGCAC-3’
Two sets of primers were used for PCR for the three SNPs. The asterisk indicates that the same set of primer was used for
rs1048661 and rs3825942.
TABLE 2. THE CLINICAL FEATURES OF THE PATIENTS WITH XFS/XFG.
Clinical features
Total (n=50)
XFG                   XFS with high IOP
 (n=42)                            (n=1)
XFS
(n=7)
Age at recruitment (mean ± SD) 70.20±7.57 73 71.28±8.94
Range (54-87) (73-73) (54-82)
Gender (male/female) 28/14 1/0 2/5
VCDR (mean ± SD) 0.78±0.15 0.3 0.40±0.08
History of trabeculectomy n=30 n=0 n=0
History of laser trabeculoplasty n=1 n=0 n=0
History of laser iridotomy n=3 n=0 n=0
Treated with medicine n=19 n=1 n=0
A total of 50 patients with exfoliation syndrome were recruited into this study, including 43 cases with XFG and 7 cases with
XFS  without glaucoma. Thirty out of the 43 XFG patients had trabeculectomy for more than once and 20 cases were treated
with medicine.
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2351with that obtained the first time. Therefore, non-concordance
with HWE for this SNP is not due to genotyping errors.
Allelic  association  analysis  showed  that  there  are
significant differences in the allelic distributions between the
two groups for the three SNPs (Table 3). The T allele of
rs1048661 was at a significantly higher frequency in cases
than in controls (p=6.95×10-11, OR =7.59, 95% CI: 3.87–
14.89). SNP rs3825942 was also associated with exfoliation
syndrome (p=8.00×10-4), with the at-risk allele G presenting
in 100% of patients. At rs2165241, the frequency of the C
allele  was  significantly  higher  in  cases  than  in  controls
(p=1.10×10-2, OR=5.44, 95% CI: 1.27–23.43). The genotypic
frequencies for each of the three SNPs were also compared
between  cases  and  controls  (Table  3).  The  frequency  of
genotype TT at SNP rs1048661 was significantly higher in
cases than in controls (p<1.00×10-7, OR=8.69, 95% CI: 4.15–
18.20), and the frequencies of GG and GT genotypes were
significantly lower in cases than in controls. The genotypes of
rs3825942  was  associated  with  exfoliation  syndrome
(p=3.84×10-3), with genotype GG being found in all patients,
while  GA  and  AA  were  detected  only  in  controls.  At
rs2165421,  only  two  genotypes,  i.e.,  CC  and  CT,  were
detected. The genotype CC presented at a significantly higher
frequency in cases than in controls (p=8.00×10-3), conferring
approximately sixfold increased risks to exfoliation syndrome
(OR=6.0, 95% CI: 1.37–26.37). In the conditional haplotype-
based  association  test,  rs1048661  had  an  independent
haplotypic effect after controlling for the other two SNPs
(p=3.6×10-7),  while  rs3825942  (p=0.0147)  and  rs2165241
(p=0.498) did not have an independent haplotypic effect after
controlling  for  the  other  two  SNPs.  Moreover,  after
controlling for rs1048661, the other two SNPs were no longer
associated with the disorder (p=0.0462).
Pairwise LD analysis showed that SNPs rs1048661 and
rs3825942  were  in  strong  LD  (Coefficient  of  linkage
disequilibrium [D’] =1.000, LOD score [LOD] =6.96), SNPs
rs1048661  and  rs2165241  were  also  in  LD  (D’=0.913,
LOD=5.14), but rs3825942 and rs2165241 were not in LD
(D’=0.007, LOD=0.00; Figure 1). Pairwise SNPs with an
LOD score of >3 were considered to be in LD [51].
TABLE 3. ALLELE AND GENOTYPE ASSOCIATION ANALYSIS FOR THE THREE SNPS OF LOXL1.
SNP
XFS/XFG (n=50)
Count (proportion)
Control (n=125)
Count (proportion) x2 p value OR (95%CI)
rs1048661
Allele
T 89 (0.89) 129 (0.52) 42.53 6.95×10-11 7.59 (3.87-14.89)
G 11 (0.11) 121 (0.48)
Genotype
TT 43 (0.86) 27 (0.22) 67.72 <0.001 8.69 (4.15-18.20)**
GT 3 (0.06) 75 (0.60)
GG 4 (0.08) 23 (0.18)
Total 43/3/4 (TT/GT/GG) 27/75/23 (TT/GT/GG) 61.72 3.97×10-15 NA
rs3825942
Allele
G 100 (1.00) 224 (0.90) 11.24 8.00×10-4 NA*
A 0 (0.00) 26 (0.10)
Genotype
GG 50 (1.00) 101 (0.80) 11.13 3.84×10-3 NA*
GA 0 (0.00) 22 (0.18)
AA 0 (0.00) 2 (0.02)
Total 50/0/0 (GG/GA/AA) 101/22/2 (GG/GA/AA) 17.63 3.84×10-3 NA
rs2165241
Allele
C 98 (0.98) 225 (0.90) 6.42 0.01 5.44 (1.27-23.43)
T 2 (0.02) 25 (0.10)
Genotype
CC 48 (0.96) 100 (0.80) 7.01 8.00×10-3 6.0 (1.37-26.37)**
CT 2 (0.04) 25 (0.20)
TT 0 (0.00) 0 (0.00)
Total 48/2/0 (CC/CT/TT) 100/25/0 (CC/CT/TT) 7.01 8.00×10-3 NA
There were significant differences for the allelic proportion between case and control groups for all the three SNPs. T allele of
rs1048661, G of rs3825942, and C of rs2165241 were risk alleles for the disorder. The genotypes TT for rs1048661, GG for
rs3825942, and CC for rs2165241 were “risk” genotypes for the disease. Total indicate the general test of association in the 2-
by-3 table of disease-by-genotype. NA: not available. The single asterisks indicate that all patients had G allele and genotype
of GG for rs3825942, so the OR values couldn’t be calculated. The double asterisks indicate the OR values and p values derived
from comparision of the specific genotype with all the others, i.e., TT versus GT+GG at rs1048661, CC versus CT+TT at
rs2165241.
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2352Haplotypes defined by the three SNPs were analyzed
(Table  4).  For  the  SNPs  rs1048661  and  rs3825942,  three
haplotypes were observed. The haplotype T-G was identified
to  be  significantly  associated  with  exfoliation  syndrome,
conferring an approximately sevenfold increased risk to the
disease (OR=6.77, 95% CI: 2.69–17.03, p<1.00×10-3). The
haplotype G-A was observed only in controls. For the SNPs
rs1048661 and rs2165241, four haplotypes were observed,
among which the haplotype T-C was significantly associated
with an increased susceptibility of XFS (OR=6.99, 95% CI:
2.78–17.58,  p<1.00×10-3).  For  the  SNPs  rs3825942  and
rs2165241,  three  haplotypes  were  observed,  with  the
haplotype G-C being at a significantly higher frequency in
cases than in controls (p=0.002, OR=12.18, 95% CI: 1.61–
92.09). The haplotype A-C was only observed in controls. The
haplotypes  for  the  three  SNPs  were  also  estimated.  The
haplotype T-G-C was at a significantly higher frequency in
cases than in controls (p<1.00×10-3, OR=6.77, 95% CI: 2.69–
17.03). Besides, the haplotype T-G-T was observed only in
cases, while the haplotypes G-A-C and G-A-T were observed
in controls exclusively.
The at-risk alleles and genotypes of the three SNPs were
analyzed for their abilities to predict the affection status (Table
5). High SE (87.7%, 95% CI: 78.6–96.8%) but low SP (19.8%,
95%  CI:  12.8–26.8%)  was  found  for  the  T  allele  of
rs1048661. The TT genotype of this SNP was with increased
SP (77.1%, 95% CI: 69.7–84.5%) and high SE (82.3%, 95%
Figure 1. Analysis of linkage disequilibrium (LD) among the three
SNPs  of  LOXL1.  The  SNPs  rs1048661  and  rs3825942,  and
rs1048661 and rs2165241 were in strong LD, but rs3825942 and
rs2165241 were not in LD. The numbers “91” and “0” in the check
indicate 100×D’ (D’ means coefficient of linkage disequilibrium).
CI: 71.7–92.9%). Although the NPVs were high, the PPVs
were low for the risk alleles and genotypes of all three SNPs.
The allelic, genotypic, and haplotypic frequencies of the
three  SNPs  between  the  two  sub-phenotypes,  i.e.,  XFS
without glaucoma and XFG, were not significantly different
(p>0.05, data not shown).
DISCUSSION
The association between the LOXL1 gene and XFS/XFG in
the Chinese population has rarely been reported except in one
recent report from Singapore [46]. In this present study, three
major LOXL1 SNPs were found to be significantly associated
with XFS/XFG, even though the sample size was as small as
50. Hence, the effect sizes of these SNPs in the Chinese
populaton  were  large,  and  50  samples  provided  a  good
statistical  power  to  detect  significant  association.  In  the
Chinese population, however, it is usually difficult to recruit
a  large  sample  of  XFS/XFG  because  of  the  low  disease
prevalence  (0.2–0.7%)  in  this  ethnic  group  [15,16].  The
reason for the low prevalence in Chinese individuals is still
unknown. Similarly, the prevalence of this disorder is also
relatively  low  in  Japanese  and  other  Asian  populations
compared with the Caucasian populations [12–14]. Such a
discrepancy  in  disease  prevalence  might  not  be  fully
explained by the ethnic difference in the frequencies of the at-
risk alleles at the LOXL1 SNPs (Table 6). Hence, other genetic
and/or environmental factors, yet to be identified, might be
involved in the development of the disorder.
In this present study, the association between the three
LOXL1  SNPs  and  XFS  /XFG  has  been  replicated  in  the
Chinese cases. However, like the findings reported from the
Japanese  population  [40–45],  the  risk  alleles  at  SNPs
rs1048661  and  rs2165241  were  different  from  that  in
Caucasian populations, as shown in Table 6. The risk allele T
at SNP rs1048661 was found to confer a 7.6-fold increased
risk to XFS/XFG (95% CI: 3.87–14.89, p=6.95×10-11), while
the homozygous genotype TT was found to have an even
larger effect size, with an OR of 8.69 (95% CI: 4.15–18.20,
p<1.00×10-7).  The  reasons  for  the  discrepancy  in  the
genotypic distributions of this SNP among XFS/XFG patients
with  different  ethnicities  remain  unknown.  Conditional
haplotype-based association test showed that rs1048661 had
independent haplotyic effect (p=3.6×10-7), and the association
between the other two SNPs and the disorder was no longer
significant  after  controlling  for  rs1048661  (p=0.0462),
suggesting that this SNP is the major SNP contributing to the
association. Moreover, in one study in an Indian population
and  one  study  in  a  Singaporean  Chinese  population,  no
association was found for rs1048661 with the disorder [39,
46]. In an American study, the rs1048661 was not associated
with the disorder after controlling the other two SNPs [35].
These findings suggest that there are other yet-to-be-identified
modifier factors (environmental or genetic) among different
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the  association  profiles  of  LOXL1  and  XFS/XFG  were
distinctively  different  between  Beijing  Chinese  and
Singaporean Chinese cases [46], further investigations of this
association from multiple centers are needed to unravel the
role of LOXL1 in the genetics of XFS/XFG among the Chinese
population.
The SNP rs1048661 is located in the first exon of the
LOXL1 gene and leads to a substitution of amino acids at
position  141  [25].  The  effect  of  such  a  substitution  on
LOXL1 mRNA expression has been investigated in order to
provide clues on the role of this SNP in the pathogenesis of
XFS/XFG. Thorleifsson and colleagues observed a decrease
of 7.7% in LOXL1 mRNA expression in adipose tissue of
Caucasian patients with the G allele [25], whereas Kazuhiko
and colleagues did not observe any change of LOXL1 mRNA
expression in lens capsule from Japanese XFG patients [45].
On the other hand, irrespective of individual genotype, ocular
TABLE 4. HAPLOTYPE ASSOCIATION ANALYSIS BETWEEN THE LOXL1 SNPS AND XFS/XFG
Haplotype
Proportion
x2 p value
OR
(95%CI) Case Control
rs1048661 rs3825942
T G   0.89 0.516 22.09 <1.00×10-3 6.77 (2.69 - 17.03)
G G   0.11 0.38 11.67 0.001 0.22 (0.09 - 0.55)
G A   0 0.104 4.21 0.04 NA *
Total     NA NA 20.36 <1.00×10-3 NA
rs1048661 rs2165241
T C   0.88 0.516 20.47 <1.00×10-3 6.99 (2.78 - 17.58)
G T   0.01 0.1 8.12 0.004 0.08 (0.01 - 0.62 )
T T   0.01 0 2.52 0.112 NA *
G C   0.1 0.384 13.64 <1.00×10-3 0.18 (0.07 - 0.48)
Total     NA NA 19.70 <1.00×10-3 NA
rs3825942 rs2165241  
G C   0.98 0.8 9.15 0.002 12.18 (1.61 - 92.09)
G T   0.02 0.1 1.95 0.163 NA *
A C   0 0.1 9.159 0.002 0.001(0 - inf)
Total     NA NA 13.45 0.001 NA
rs1048661 rs3825942 rs2165241
T G C 0.88 0.516 19.70 <1.00×10-3 6.77 (2.69 - 17.03)
G G C 0.1 0.29 7.04 0.008 0.28 (0.10 - 0.75)
G G T 0.01 0.09 2.59 0.108 NA
T G T 0.01 0 2.51 0.113 NA *
G A C 0 0.094 3.76 0.052 NA *
G A T 0 0.01 0.40 0.526 NA *
Total     NA NA 20.37 <1.00×10-3 NA
The haplotypes T-G, T-C and G-C for the SNPs rs1048661   and  rs3825942, rs1048661 and rs2165241, and rs3825942 and
rs2165241 were identified to be significantly associated with XFS, respectively. The haplotype T-G-C for the three SNPs was
identified to be significantly associated with XFS. Total indicate omnibus tests, while the others indicate  the  haplotype-specific
tests. The OR values were obtained from comparision of each individual haplotype with all the other haplotypes, i.e., T-G versus
G-G + G-A for the SNPs rs1048661 and  rs3825942, et al. NA: not available. The asterisks indicate that the OR  values  were
not available since differences between cases and controls were not significant for these haplotypes (p>0.017).
TABLE 5. THE SENSITIVITY, SPECIFICITY, POSITIVE AND NEGATIVE PREDICTIVE VALUES FOR THE RISK ALLELES AND GENOTYPES OF THE THREE SNPS OF LOXL1.
SNP SE (95%CI) SP (95%CI) PPV (95%CI) NPV (95%CI)
rs1048661
allele (T) 0.877(0.786-0.968) 0.198(0.128-0.268) 0.0022(0.0019-0.0025) 0.9988(0.9988-1.00)
genotype (TT) 0.823(0.717-0.929) 0.771(0.697-0.845) 0.0072(0.0047-0.0097) 0.9995(0.9992-0.9998)
rs3825942
allele (G) 0.948(0.886-1.00) 0.037(0.004-0.070) 0.0020(0.0019-0.0021) 0.9972(0.9930-1.00)
genotype (GG) 0.948(0.886-1.00) 0.206(0.135-0.277) 0.0024(0.0021-0.0027) 0.9995(0.9989-1.00)
rs2165241
allele (C) 0.948(0.886-1.00) 0.022(0.004-0.048) 0.0019(0.0017-0.0020) 0.9953(0.9875-1.00)
genotype (CC) 0.912(0.833-0.991) 0.213(0.141-0.285) 0.0023(0.0020-0.0026) 0.9992(0.9984-1.00)
SE, SP, PPV and NPV indicate sensitivity, specificity, positive and negative predictive values, respectively. High SE (82.3%)
and high SP (77.1%) were found at the TT genotype of rs1048661.
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2354LOXL1 expression was found to be differentially regulated in
different  stages  of  the  disorder.  The  LOXL1  mRNA
expression  was  upregulated  in  the  early  stage  but  was
decreased  in  an  advanced  stage  [30].  Further  studies  are
needed to clarify the role of this SNP in the expression of
LOXL1 and subsequently in the pathogenesis of this disorder.
Besides  rs1048661,  SNPs  rs3825942  and  rs2165241
were  also  significantly  associated  with  XFS/XFG
individually. However, when controlled for rs1048661, the
association became insignificant, suggesting they are more
likely to be genetic markers in LD with the rs1048661. The
rs3825942 was associated with the disorder in Caucasians
[25,35]  and  Japanese  [43].  However,  this  SNP  has  no
functional impact on the LOXL1 mRNA level in adipose tissue
[25]  or  anterior  lens  capsule  [45].  Concerning  the  SNP
rs2165241,  which  is  located  in  the  intronic  region,  the
functional impact of this SNP remains unknown. Similar to
SNP  rs1048661,  the  association  profile  of  rs2165241
resembles  that  in  a  Japanese  population  [43,44]  but  was
opposite to the Caucasians [25,34].
In this present study, although the sample size of XFS
without glaucoma was small (n=7), the allelic and genotypic
frequencies of the three SNPs in the two sub-phenotypes were
similar and had no statistical significance. This finding is
consistent with other studies [25]. The LOXL1 gene is more
likely a susceptibility gene for XFS rather than a triggering
factor for the development of XFG, and there may be other
genetic  or  environmental  factors  predisposing  individuals
toward XFG.
High  SE  and  SP  for  the  risk  genotype  TT  at  SNP
rs1048661 (82.3%, 95% CI: 71.7–92.9% and 77.1%, 95% CI:
69.7–84.5%) imply the potential value of the diagnostic test
for  XFS,  although  further  studies  are  needed.  However
applying  genotyping  of  the  SNPs  was  inappropriate  in
screening patients with XFS among this Chinese population
due to low PPVs (Table 5).
In summary, we confirmed the results that the three SNPs
of LOXL1 are associated with XFS/XFG, but the risk alleles
at rs1048661 and rs2165241 in this present study are opposite
to Caucasian populations. The rs1048661 is the predominant
SNP associated with XFS/XFG in our study cohort. The role
of this SNP in pathogenesis of the disorder needs to be studied
further, and further investigations are also needed to unravel
additional genetic or environmental factors modifying the
development of this disorder.
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